Updated on 2022/03/28

写真a

 
FUKUMOTO Koichi
 
Organization
Nagoya University Hospital Thoracic Surgery Lecturer of hospital
Title
Lecturer of hospital

Degree 1

  1. 博士(医学) ( 2014.10   名古屋大学 ) 

Research History 1

  1. Nagoya University   Lecturer of hospital

    2021.4

Education 2

  1. Nagoya University   Graduate School, Division of Medical Sciences

    - 2014.3

      More details

    Country: Japan

  2. Nagoya University   Faculty of Medicine

    - 2002.3

      More details

    Country: Japan

Professional Memberships 9

  1. 日本外科学会

  2. 日本呼吸器外科学会

  3. 日本肺がん学会

  4. 日本胸部外科学会

  5. 日本胸腺研究会

  6. 日本癌学会

  7. 日本疫学会

  8. International Association for the Study of Lung Cancer

  9. 日本移植学会

▼display all

Committee Memberships 1

  1.   日本肺癌学会ガイドライン検討委員会胸腺腫瘍小委員会委員  

       

 

Papers 14

  1. Impact of the preoperative body mass index on the postoperative outcomes in patients with completely resected non-small cell lung cancer: A retrospective analysis of 16,503 cases in a Japanese Lung Cancer Registry Study Reviewed

    Lung Cancer     2020.11

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

  2. Risk Assessment for Loss-of-Exercise Capacity After Lung Cancer Surgery: Current Advances in Surgery and Systemic Treatment

    Ozeki Naoki, Kadomatsu Yuka, Mizuno Yota, Inoue Takayuki, Nagaya Motoki, Goto Masaki, Nakamura Shota, Fukumoto Koichi, Chen-Yoshikawa Toyofumi Fengshi

    WORLD JOURNAL OF SURGERY   Vol. 46 ( 4 ) page: 933 - 941   2022.4

     More details

    Language:Japanese   Publisher:World Journal of Surgery  

    Background: Considering advances in current post-recurrence treatment, we examined the prognostic significance of the number of risk factors for loss-of-exercise capacity (LEC) after lung cancer surgery, which were identified by our previous prospective observational study. Methods: Risk factors for LEC were defined as a short baseline 6-min walk distance (<400 m), older age (≥75 years), and low predicted postoperative diffusing capacity for carbon monoxide (<60%). Patients were classified as Risk 0/I/II/III according to the number of risk factors. The survival data were retrospectively analyzed. Results: Between 2014 and 2017, 564 patients (n = 307, 193, 57, 7; Risk 0/I/II/III) who underwent lung cancer surgery were included in the study. The number of risk factors was associated with smoking status, predicted postoperative forced expiratory volume in 1 s, histology, pathological stage, and adjuvant therapy. In a multivariate Cox regression analysis, compared to Risk 0, Risk I/II/III showed significant associations with overall survival (hazard ratios: 1.92, 3.35, 9.21; 95% confidence interval: 1.27–2.92, 2.01–5.58, 3.64–23.35; Risk I/II/III, respectively). In 141 patients with recurrence, molecular targeted therapies (MTTs) or immune checkpoint inhibitors (ICIs) were included in 58%, 47%, 32%, and 0% (Risk 0/I/II/III) during the course of treatment. In patients with MTT/ICI treatment, the estimated 1-year and 3-year post-recurrence survival rates were 88% and 58%, respectively. Conclusions: Risk classification for LEC was associated with survival after lung cancer surgery, as well as post-recurrence treatment. The concept of physical performance-preserving surgery may contribute to improving the outcomes of current lung cancer treatment.

    DOI: 10.1007/s00268-021-06427-3

    Web of Science

    Scopus

    PubMed

  3. Relationship of smoking cessation period with the incidence of complications in lung cancer surgery.

    Kadomatsu Y, Sugiyama T, Sato K, Nakanishi K, Ueno H, Goto M, Ozeki N, Nakamura S, Fukumoto K, Chen-Yoshikawa TF

    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery     2022.3

     More details

    Language:English  

    DOI: 10.1093/ejcts/ezac163

    PubMed

  4. Prognostic Value of Uncertain Resection for Overall Survival in Non-small Cell Lung Cancer

    Kadomatsu Y., Nakamura S., Ueno H., Goto M., Ozeki N., Fukumoto K., Fukui T., Suzuki Y., Chen-Yoshikawa T.F.

    Annals of Thoracic Surgery     2021

     More details

    Language:Japanese   Publisher:Annals of Thoracic Surgery  

    Background: In this study we evaluated the R(un) category proposed by the International Association for the Study of Lung Cancer (IASLC) for non-small cell lung cancer (NSCLC). Methods: We retrospectively reviewed the medical records of patients with NSCLC who underwent segmentectomy or lobectomy between 2014 and 2015 at our institution. Residual tumor (R) status was reclassified from the Union for International Cancer Control designation to the IASLC-proposed R classification of R0 and R(un). The underlying reasons for the R(un) reclassification were analyzed according to pathologic stage, lymph node status, and resected lobe. A Cox proportional hazard model was used to evaluate the impacts of R(un) categorization on overall survival. Results: Of 355 patients, 44.5% were reclassified as R(un). The most common reason for the reclassification was insufficient number of harvested lymph nodes or no station 7 lymph nodes. When stratified by tumor location, the absence of station 7 lymph nodes was especially prominent in both the right and left upper lung resections. In the multivariate Cox regression model, the IASLC R classification was associated with poor overall survival in node-positive patients (hazard ratio, 2.657; P =.016). Conclusions: Various factors resulted in reclassification to R(un) because the R(un) group was highly heterogeneous. Careful consideration is required to determine whether the R(un) classification can be used as an indicator of lymph node dissection quality. For advanced cases, the R(un) definition may be useful in predicting poor prognosis.

    DOI: 10.1016/j.athoracsur.2021.07.087

    Scopus

    PubMed

  5. Commentary: Look Before You Leap

    Fukumoto K., Chen-Yoshikawa T.F.

    Seminars in Thoracic and Cardiovascular Surgery     2021

     More details

    Language:Japanese   Publisher:Seminars in Thoracic and Cardiovascular Surgery  

    DOI: 10.1053/j.semtcvs.2021.06.018

    Scopus

    PubMed

  6. Lobectomy with bronchoplasty and pulmonary arterial angioplasty for lung cancer after correction of contralateral partial anomalous pulmonary venous connection Reviewed

    Surg Case Rep     2020.12

     More details

    Authorship:Lead author, Corresponding author   Language:English  

  7. The tumor doubling time is a useful parameter for predicting the histological type of thymic epithelial tumors. Invited Reviewed

    Surgery Today     2019.8

  8. Collaborative operation with cardiovascular surgeons in general thoracic surgery. Invited Reviewed

    Gen Thorac Cardiovasc Surg     2017.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  9. The Role of 18F-fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for Predicting Pathologic Response After Induction Therapy for Thymic Epithelial Tumors. Reviewed

    Fukumoto K, Fukui T, Okasaka T, Kawaguchi K, Nakamura S, Hakiri S, Ozeki N, Sugiyama T, Kato K, Yokoi K.

    World journal of Surgery     2017.3

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007

  10. Cigarette smoke inhalation and risk of lung cancer: a case-control study in a large Japanese population. Reviewed

    Fukumoto K, Ito H, Matsuo K, Tanaka H, Yokoi K, Tajima K, Takezaki T.

    European journal of Cancer Prevention   Vol. 24 ( 3 ) page: 195-200   2015.5

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  11. Preoperative plasma D-dimer level is an independent prognostic factor in patients with completely resected non-small cell lung cancer. Reviewed

    Fukumoto K, Taniguchi T, Usami N, Kawaguchi K, Fukui T, Ishiguro F, Nakamura S, Yokoi K.

    Surgery Today   Vol. 45 ( 1 ) page: 63-7   2015.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  12. The ABO blood group is an independent prognostic factor in patients with resected non-small cell lung cancer Reviewed

    Fukumoto K, Taniguchi T, Usami N, Kawaguchi K, Fukui T, Ishiguro F, Nakamura S, Yokoi K.

    Journal of Epidemiology   Vol. 25 ( 2 ) page: 110-6   2015

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  13. The utility of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours. Reviewed

    Fukumoto K, Taniguchi T, Ishikawa Y, Kawaguchi K, Fukui T, Kato K, Matsuo K, Yokoi K.

    European journal of Cardiothoracic Surgery   Vol. 42 ( 6 ) page: e152-6   2012.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  14. Late breast metastasis from resected lung cancer diagnosed by epidermal growth factor receptor gene mutation. Reviewed

    Fukumoto K, Usami N, Okasaka T, Kawaguchi K, Okagawa T, Suzuki H, Yokoi K.

    Lung Cancer   Vol. 74 ( 2 ) page: 352-3   2011.11

     More details

    Authorship:Lead author   Language:English  

▼display all